Chief Executive Officer
Adam is an experienced commercial leader with over 20 years experience working globally across start up and market leading companies within Diagnostics, Pharmaceuticals, Medical Device, and SaaS companies most notably MSD, Abbott, LivaNova and Coloplast. He has built numerous sales and marketing teams and his strategic acumen combined with creative marketing enables him to devise and implement plans which drive revenue and enable companies to make a difference to the patients and physicians they serve. Passionate about the world of point of care testing since his time at Abbott, Adam has built a strong network of contacts and advocates globally with the aim of making point of care accessible to all patients who deserve and require immediate test results.
Chief Scientific Officer
Gary is a highly distinguished scientist with a strong history of success leading research in viral vaccines and immunology, backed by an exhaustive list of peer-reviewed publications, industry collaborations, grant supports, patent filling, book chapter contribution, and oral presentations.
Throughout his career, Gary has successfully guided biomedical innovation, shaped experimental design and analysis, and led the publication of scientific papers in line with industry-specific vaccine development strategy. His expertise involves Molecular Immunology, Respiratory Medicine, Biomedical Sciences, Rhinovirus Infections, Clinical Research & Trials, Virology, Pathology, Epidemiology, Vaccinology, mRNA Techniques, Antibodies, as well as the recent SARS-CoV-2 Mutations and Variants.
He was invited to share his expert opinion on over 150 radio, television, print, and online interviews during the COVID-19 pandemic. Until joining PremaLabs he was Professor of Molecular Immunology at LMU. He is now Professor Emeritus at LMU and retains his role as Honorary Senior Research Fellow at Imperial College London.
Chief Operating Officer
Eric has spent over 20 years growing and transforming businesses across a variety of sectors and leading multi-million dollar change projects in over 30 different countries. A graduate of London Business School, Eric has worked with over a dozen businesses, from small start-ups to large conglomerates such as Time Warner and P&G and was a member of the Operational Turnaround team for private equity firm Terra Firma Capital Partners during their $4.7b takeover of EMI Music. Later in his career, as SVP of International Business Transformation for The Interpublic Group of Companies, Eric helped improve underperforming business units across the company’s 65,000 person network and led operations for teams working with clients such as Pfizer, J&J and Coca Cola. At PremaLabs, Eric is focused on the strategic development and market entry within the United Kingdom and building the operations to support these activities.
Marketing & PR Director
Wendy is a chartered marketer and professional communicator with over 30 years’ experience of strategic and operational B2B/B2C marketing including 10 years within a variety of healthcare manufacturing and service industries, most recently working within POCT with LumiraDx.